143 related articles for article (PubMed ID: 36762827)
1. Identification and Validation of Molecular Subtype and Prognostic Signature for Bladder Cancer Based on Neutrophil Extracellular Traps.
Tu Y; Mao Z
Cancer Invest; 2023 Apr; 41(4):354-368. PubMed ID: 36762827
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps.
Zuo Y; Leng G; Leng P
Pathol Oncol Res; 2023; 29():1610899. PubMed ID: 37143472
[No Abstract] [Full Text] [Related]
3. A neutrophil extracellular traps-related classification predicts prognosis and response to immunotherapy in colon cancer.
Feng C; Li Y; Tai Y; Zhang W; Wang H; Lian S; Jin-Si-Han EE; Liu Y; Li X; Chen Q; He M; Lu Z
Sci Rep; 2023 Nov; 13(1):19297. PubMed ID: 37935721
[TBL] [Abstract][Full Text] [Related]
4. The neutrophil extracellular traps-related gene signature predicts the prognosis of glioblastoma multiforme.
Sun G; Liu W
Folia Neuropathol; 2024; 62(1):59-75. PubMed ID: 38174685
[TBL] [Abstract][Full Text] [Related]
5. Identification of Molecular Subtype and Prognostic Signature for Prostate Adenocarcinoma based on Neutrophil Extracellular Traps.
Zheng Y; Sun H; Yang S; Liu W; Jiang G
J Cancer; 2024; 15(9):2678-2690. PubMed ID: 38577608
[No Abstract] [Full Text] [Related]
6. Identification and validation of the molecular subtype and prognostic signature for clear cell renal cell carcinoma based on neutrophil extracellular traps.
Quan J; Huang B
Front Cell Dev Biol; 2022; 10():1021690. PubMed ID: 36523511
[No Abstract] [Full Text] [Related]
7. Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored
Herranz R; Oto J; Hueso M; Plana E; Cana F; Castaño M; Cordón L; Ramos-Soler D; Bonanad S; Vera-Donoso CD; Martínez-Sarmiento M; Medina P
Front Immunol; 2023; 14():1171065. PubMed ID: 37275882
[TBL] [Abstract][Full Text] [Related]
8. Prediction of prognosis and immunotherapy response in breast cancer based on neutrophil extracellular traps-related classification.
Zhao J; Xie X
Front Mol Biosci; 2023; 10():1165776. PubMed ID: 37304069
[TBL] [Abstract][Full Text] [Related]
9. A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer.
Fang C; Liu F; Wang Y; Yuan S; Chen R; Qiu X; Qian X; Zhang X; Xiao Z; Wang Q; Fu B; Li Y
Aging (Albany NY); 2021 Jul; 13(13):17864-17879. PubMed ID: 34257164
[TBL] [Abstract][Full Text] [Related]
10. Identification of an immune gene-associated prognostic signature in patients with bladder cancer.
Wang Z; Zhu L; Li L; Stebbing J; Wang Z; Peng L
Cancer Gene Ther; 2022 May; 29(5):494-504. PubMed ID: 35169299
[TBL] [Abstract][Full Text] [Related]
11. Identification of bladder cancer subtypes and predictive model for prognosis, immune features, and immunotherapy based on neutrophil extracellular trap-related genes.
Guo C; Li P; Guo X; Wang X; Liu B; Cui L
Sci Rep; 2023 Nov; 13(1):20791. PubMed ID: 38012244
[TBL] [Abstract][Full Text] [Related]
12. Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma.
He X; Xiao Y; Liu S; Deng R; Li Z; Zhu X
Biomed Res Int; 2022; 2022():3191474. PubMed ID: 36147630
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of neutrophil extracellular traps-derived signature to predict the prognosis for osteosarcoma patients.
Lin Y; Tang H; Teng H; Feng W; Li F; Liu S; Liu Y; Wei Q
Int Immunopharmacol; 2024 Jan; 127():111364. PubMed ID: 38101221
[TBL] [Abstract][Full Text] [Related]
14. A neutrophil extracellular traps-associated lncRNA signature predicts the clinical outcomes in patients with lung adenocarcinoma.
Ding W; Li B; Zhang Y; He L; Su J
Front Genet; 2022; 13():1047231. PubMed ID: 36419832
[No Abstract] [Full Text] [Related]
15. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer.
Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465
[TBL] [Abstract][Full Text] [Related]
16. Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer.
Luo Y; Chen L; Zhou Q; Xiong Y; Wang G; Liu X; Xiao Y; Ju L; Wang X
J Cell Mol Med; 2020 Nov; 24(22):13370-13382. PubMed ID: 33048468
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil extracellular traps-related signature predicts the prognosis and immune infiltration in gastric cancer.
Li M; Zhao Z; Mak TK; Wang X; Chen J; Ren H; Yu Z; Zhang C
Front Med (Lausanne); 2023; 10():1174764. PubMed ID: 37636564
[TBL] [Abstract][Full Text] [Related]
18. A signature for pan-cancer prognosis based on neutrophil extracellular traps.
Zhang Y; Guo L; Dai Q; Shang B; Xiao T; Di X; Zhang K; Feng L; Shou J; Wang Y
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35688556
[TBL] [Abstract][Full Text] [Related]
19. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
Wang Z; Tu L; Chen M; Tong S
BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer.
Chen J; Liao Y; Li R; Luo M; Wu G; Tan R; Xiao Z
Technol Cancer Res Treat; 2022; 21():15330338221090093. PubMed ID: 35509211
[No Abstract] [Full Text] [Related]
[Next] [New Search]
